Circulating endothelial progenitor cells (EPCs) may contribute to vascular endothelial cell homeostasis, and low levels of these cells are predictive of cardiovascular disease. We hypothesized that circulating EPCs increase in number during uncomplicated pregnancy but are reduced in women with preeclampsia. Peripheral blood was obtained from pregnant women and from nulligravidas in cross-sectional design. Cells expressing CD34 or CD133, in combination with vascular endothelial growth factor receptor-2 (VEGFR-2), were enumerated by flow cytometry. Both CD34+VEGFR-2+ (doubly positive) and CD133+VEGFR-2 + cells were significantly increased during the second and third trimesters of uncomplicated pregnancy compared to the first trimester. First trimester and nulligravida groups did not differ. Endothelial progenitor cells, quantified by flow cytometry or by circulating angiogenic cell (CAC) culture assay, were significantly reduced in women with preeclampsia compared to third trimester controls. Circulating EPCs appear to increase during normal pregnancy, and comparatively reduced numbers of these cells exist during preeclampsia.
Taylor RN, Davidge ST, Roberts JMEndothelial cell dysfunction and oxidative stress. In: Lindheimer MD, Roberts JM , Cunningham FG, eds. Chesley’s Hypertensive Disorders in Pregnancy. Vol Third Edition. Elsevier, Inc ; Boston, MA: 2009:143-167.
2.
Stillman IE, Karumanchi SAThe glomerular injury of preeclampsia. J Am Soc Nephrol . 2007;18(8):2281-2284.
3.
Khong TYAcute atherosis in pregnancies complicated by hypertension, small-for-gestational-age infants, and diabetes mellitus. Arch Pathol Lab Med. 1991;115(7):722-725.
4.
Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R.Isolation of putative progenitor endothelial cells for angiogenesis . Science. 1997;275:964-967.
5.
Case J., Ingram DA, Haneline LSOxidative stress impairs endothelial progenitor cell function. Antioxid Redox Signal. 2008;10(11):1895-1907.
6.
Timmermans F. , Plum J., Yoder MC, Ingram DA, Vandekerckhove B., Case J.Endothelial progenitor cells: identity defined?J Cell Mol Med. 2009 ;13(1):87-102.
7.
Hirschi KK, Ingram DA, Yoder MCAssessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008 ;28(9):1584-1595.
8.
Shantsila E. , Watson T., Tse HF, Lip GYNew insights on endothelial progenitor cell subpopulations and their angiogenic properties. J Am Coll Cardiol. 2008;51(6):669-671.
9.
Sieveking DP , Buckle A., Celermajer DS, Ng MKStrikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol. 2008 ;51(6):660-668.
10.
Sirker AA, Astroulakis ZM, Hill JMVascular progenitor cells and translational research: the role of endothelial and smooth muscle progenitor cells in endogenous arterial remodelling in the adult. Clin Sci (Lond). 2009;116(4):283-299.
11.
Sabatier F. , Camoin-Jau L., Anfosso F., Sampol J., Dignat-George F.Circulating endothelial cells, microparticles and progenitors: key players towards the definition of vascular competence . J Cell Mol Med. 2009;13(3):454-471.
12.
Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89(1):e1-e7.
13.
Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353(10):999-1007.
14.
Friedrich EB , Walenta K., Scharlau J., Nickenig G., Werner N.A CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities . Circ Res. 2006;98(3):e20-e25.
15.
Murphy C., Kanaganayagam GS, Jiang B., et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol. 2007;27(4):936-942.
16.
Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events, proof of concept for the clinical importance of endogenous vascular repair. Circulation . 2005; 111(22):2981-2987.
17.
Fadini GP, Coracina A., Baesso I., et al. Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population . Stroke. 2006;37(9):2277-2282.
Rafii S., Avecilla S., Shmelkov S., et al. Angiogenic factors reconstitute hematopoiesis by recruiting stem cells from bone marrow microenvironment. Ann N Y Acad Sci. 2003;996:49-60.
20.
Strehlow K. , Werner N., Berweiler J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation . Circulation. 2003; 107(24):3059-3065.
21.
Rehman J., Li J., Orschell CM, March KLPeripheral blood ‘‘endothelial progenitor cells’’ are derived from monocyte/ macrophages and secrete angiogenic growth factors . Circulation. 2003;107(8):1164-1169.
22.
Grisar J., Aletaha D., Steiner CW, et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation. 2005;111(2):204-211.
23.
Urbich C., Aicher A., Heeschen C., et al. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol. 2005;39(5):733-742.
24.
Maynard SE, Min J.-Y, Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649-658.
25.
Chesley LCHypertension in pregnancy: definitions, familial factor, and remote prognosis . Kidney Int. 1980;18(2):234-240.
26.
Heeschen C. , Lehmann R., Honold J., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation . 2004;109(13):1615-1622.
27.
Shibata E., Rajakumar A., Powers RW, et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab. 2005;90(8):4895-4903.
28.
Diller GP, van Eijl S., Okonko DO, et al. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation. 2008;117(23):3020-3030.
Buemi M., Allegra A., D’Anna R., et al. Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension. Am J Obstet Gynecol. 2007;196(1): 68.e61-68.e66.
31.
Matsubara K. , Abe E., Matsubara Y., Kameda K., Ito M.Circulating endothelial progenitor cells during normal pregnancy and pre-eclampsia. Am J Reprod Immunol. 2006;56(2):79-85.
32.
Beckmann I. , Efraim SB, Vervoort M., Visser W., Wallenburg HCTumor necrosis factor-alpha in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women . Hypertens Pregnancy. 2004;23(3): 319-329.
33.
Canzoneri B. , Lewis D., Groome L., Wang Y.Increased neutrophil numbers account for leukocytosis in women with preeclampsia. Am J Perinatol.2009;26(10):729-732.
34.
Yoon CH, Hur J., Park KW, et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells. The role of angiogenic cytokines and matrix metalloproteinases. Circulation . 2005;112(11):1618-1627.
35.
Ingram DA, Mead LE, Tanaka H., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood . 2004;104(9): 2752-2760.
36.
Xia L., Zhou XP, Zhu JH, et al. Decrease and dysfunction of endothelial progenitor cells in umbilical cord blood with maternal pre-eclampsia. J Obstet Gynaecol Res. 2007;33(4):465-474.
37.
Aicher A., Heeschen C., Mildner-Rihm C., et al. Esential role of endothelial nitric oxide synhase for mobilization of stem and progenitor cells. Nat Med. 2003 ;9(11):1370-1376.
38.
Rosenzweig A.Circulating endothelial progenitors-cells as biomarkers. N Engl J Med. 2005;353(10):1055-1057.
